Snider R M, Gerald M C
Life Sci. 1982 Aug 30;31(9):853-7. doi: 10.1016/0024-3205(82)90540-9.
This study, conducted in the rat phrenic nerve-diaphragm preparation, was designed to establish more direct evidence that norepinephrine enhances acetylcholine (ACh) release from motor neurons and characterize the alpha-adrenoceptor type mediating this action. Norepinephrine (50 microM, alpha 1 + alpha 2 agonist) increased nerve-stimulated release by 183%, as determined by radioenzymatic assay. This effect was completely abolished by pretreatment with the alpha-adrenoceptor antagonists phentolamine (alpha 1 + alpha 2) and by WB 4101 (alpha 1) but only modestly reduced by yohimbine (alpha 2). Clonidine (alpha 2 agonist) did not enhance ACh release or nerve-stimulated muscle contractions, while phenylephrine (alpha 1 agonist) and norepinephrine increased muscle contractions up to 19.5-22.4%. These results support the hypothesis that norepinephrine increases ACh release from somatic motor nerves via a presynaptic alpha 1 interaction.
本研究在大鼠膈神经-膈肌标本上进行,旨在获取更直接的证据,证明去甲肾上腺素可增强运动神经元释放乙酰胆碱(ACh),并确定介导此作用的α-肾上腺素能受体类型。通过放射酶法测定,去甲肾上腺素(50微摩尔,α1 + α2激动剂)使神经刺激释放增加了183%。α-肾上腺素能受体拮抗剂酚妥拉明(α1 + α2)和WB 4101(α1)预处理可完全消除此效应,而育亨宾(α2)仅使其适度降低。可乐定(α2激动剂)未增强ACh释放或神经刺激的肌肉收缩,而苯肾上腺素(α1激动剂)和去甲肾上腺素使肌肉收缩增加高达19.5 - 22.4%。这些结果支持以下假说:去甲肾上腺素通过突触前α1相互作用增加躯体运动神经释放ACh。